Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
3 August 2012

IN THIS ISSUE
Counterfeit medicines
Parkinson's R&D
Q2 financials
ARV advances
Regulatory experts


Medicines Top EU's Counterfeit List
A report from the European Commission shows that fake pharmaceuticals were the top articles detained by European-Union customs in 2011. Customs seized almost 115 million products suspected of being counterfeit, up from 103 million in 2010. More...
 
Merck Serono to Spin Off Parkinson's R&D
Merck Serono, a division of Merck KGaA, announced in June, 2012 that it would be closing down operations in Geneva, Switzerland as part of its restructuring activities, but providing up to EUR 30 million in funding for start-up companies to reemploy some of those displaced workers. More...
 
Second-Quarter 2012 Financial Reports Show Pfizer, Novartis Down, Merck Up
Pharmaceutical industry leaders Pfizer, Novartis, and Merck—among others—released second-quarter 2012 results, emphasizing growth of new products and strength in emerging markets. More...
 
International AIDS Conference Highlights ARV Advances
Prominent scientists and political leaders at the International AIDS Conference in the US in late July were optimistic for the first time about bringing an end to the global AIDS pandemic. More...
 
Ask the Regulatory Experts
PharmTech regularly publishes common Q&As regarding the regulation and compliance of pharmaceutical development and manufacturing. Questions are answered by former FDA officials, now in consulting roles, and we are inviting you to submit questions. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
Key Topics:

Latest blog posts
International AIDs Conference Highlights ARV Advances
FDA Asserts Authority over Stem Cell Treatments
Atypical Visible Particles: Can Users and Makers find Common Ground?
More blog posts

Latest articles
Decades of Change for the Top Pharmaceutical Companies
EMA and MHRA Provide Insight into Increased GMP Deficiencies
Changing German Market Depresses the Pharma Industry
More articles

Upcoming events
The 8th European Downstream Technology Forum (11–12 September | Germany)
Royal Pharmaceutical Society Annual Conference 2012 (9–10 September | UK)
World Drug Safety Congress Europe 2012 (11–13 September | UK)
More events

Products/Service Profiles
Pharmaceutical Press

Handbook of Pharmaceutical Excipients, NEW 7th edition. Special offer price - available now.
A new edition of the Handbook has always seen important developments, and this edition is no exception. Not only has the entire volume been reviewed and updated, significant new content has been added.
Read more

 
Shimadzu

Eliminate Ghost Peaks in UHPLC
Shimadzu has introduced the Ghost Trap™ DS-HP Series Columns which are designed to remove impurities from the solvent and system, enabling highly sensitive and reliable analysis.
Read more

 
Starna

Starna Scientific introduces new NIR Metal-on-Quartz neutral density filter Certified Reference Materials, enhancing and extending the capability to qualify the full range Transmittance scale of a UV-Vis-NIR spectrophotometer.
Read more

 

Company Profile
Roquette

Roquette is a long-established supplier of actives and excipients, associated to many services, to the pharmaceutical and cosmetics industries. Whatever your requirements and aims, discover Roquette Pharma's Solutions.
Read more


Event Profile
CPHI Worldwide

CPhI Worldwide is the world’s leading pharmaceutical networking event for Pharma Ingredients.  Along with co-located events ICSE for Contract Services, InnoPack for Innovative Packaging and P-MEC Europe for Technology, Equipment and Machinery, this is a one-stop shop event that cannot be missed by anyone serving the (Bio)Pharmaceutical industry.
Read more

Survey
Has your manufacturing site implemented an energy efficiency plan to reduce carbon footprint?
 
Yes 86%
 
 
No 13%
     
 
Not yet, but we're exploring options 1%

This week we would like to know...

Aside from China and India, which pharmerging market is your country most interested in expanding manufacturing operations into?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.